These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22233170)

  • 1. A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection.
    Jenh CH; Cox MA; Cui L; Reich EP; Sullivan L; Chen SC; Kinsley D; Qian S; Kim SH; Rosenblum S; Kozlowski J; Fine JS; Zavodny PJ; Lundell D
    BMC Immunol; 2012 Jan; 13():2. PubMed ID: 22233170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis.
    Kohler RE; Comerford I; Townley S; Haylock-Jacobs S; Clark-Lewis I; McColl SR
    Brain Pathol; 2008 Oct; 18(4):504-16. PubMed ID: 18422759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.
    Uppaluri R; Sheehan KC; Wang L; Bui JD; Brotman JJ; Lu B; Gerard C; Hancock WW; Schreiber RD
    Transplantation; 2008 Jul; 86(1):137-47. PubMed ID: 18622291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
    Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
    Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine receptor CXCR3: an unexpected enigma.
    Liu L; Callahan MK; Huang D; Ransohoff RM
    Curr Top Dev Biol; 2005; 68():149-81. PubMed ID: 16124999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft.
    Jiankuo M; Xingbing W; Baojun H; Xiongwin W; Zhuoya L; Ping X; Yong X; Anting L; Chunsong H; Feili G; Jinquan T
    J Immunol; 2003 Feb; 170(3):1556-65. PubMed ID: 12538721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
    Stanford MM; Issekutz TB
    J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
    Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
    J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis.
    Lee JH; Kim B; Jin WJ; Kim HH; Ha H; Lee ZH
    Arthritis Res Ther; 2017 Jul; 19(1):163. PubMed ID: 28724396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of autoimmune diseases.
    Marques A; Müller S
    Curr Drug Discov Technol; 2009 Dec; 6(4):262-9. PubMed ID: 20025594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3.
    Scholten DJ; Canals M; Wijtmans M; de Munnik S; Nguyen P; Verzijl D; de Esch IJ; Vischer HF; Smit MJ; Leurs R
    Br J Pharmacol; 2012 Jun; 166(3):898-911. PubMed ID: 21883151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR3 antagonist AMG487 suppresses rheumatoid arthritis pathogenesis and progression by shifting the Th17/Treg cell balance.
    Bakheet SA; Ansari MA; Nadeem A; Attia SM; Alhoshani AR; Gul G; Al-Qahtani QH; Albekairi NA; Ibrahim KE; Ahmad SF
    Cell Signal; 2019 Dec; 64():109395. PubMed ID: 31449849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3.
    Nedjai B; Li H; Stroke IL; Wise EL; Webb ML; Merritt JR; Henderson I; Klon AE; Cole AG; Horuk R; Vaidehi N; Pease JE
    Br J Pharmacol; 2012 Jun; 166(3):912-23. PubMed ID: 21895630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis.
    Mohan K; Issekutz TB
    J Immunol; 2007 Dec; 179(12):8463-9. PubMed ID: 18056393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo immunopharmacological profile of Sch 40120.
    Smith SR; Watnick AS; Kung T; Siegel MI
    Immunopharmacol Immunotoxicol; 1993 Jan; 15(1):13-44. PubMed ID: 8450179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors.
    Verzijl D; Storelli S; Scholten DJ; Bosch L; Reinhart TA; Streblow DN; Tensen CP; Fitzsimons CP; Zaman GJ; Pease JE; de Esch IJ; Smit MJ; Leurs R
    J Pharmacol Exp Ther; 2008 May; 325(2):544-55. PubMed ID: 18270317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemisinin Attenuates Transplant Rejection by Inhibiting Multiple Lymphocytes and Prolongs Cardiac Allograft Survival.
    Yang Z; Han F; Liao T; Zheng H; Luo Z; Ma M; He J; Li L; Ye Y; Zhang R; Huang Z; Zhang Y; Sun Q
    Front Immunol; 2021; 12():634368. PubMed ID: 33717174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
    Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP
    J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Zisman DA; Xue YY; Li K; Ardehali A; Ross DJ; Strieter RM
    J Immunol; 2003 Nov; 171(9):4844-52. PubMed ID: 14568964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344.
    Brodmerkel CM; Huber R; Covington M; Diamond S; Hall L; Collins R; Leffet L; Gallagher K; Feldman P; Collier P; Stow M; Gu X; Baribaud F; Shin N; Thomas B; Burn T; Hollis G; Yeleswaram S; Solomon K; Friedman S; Wang A; Xue CB; Newton RC; Scherle P; Vaddi K
    J Immunol; 2005 Oct; 175(8):5370-8. PubMed ID: 16210643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.